Because non-alcoholic steatohepatitis (NASH), the progressive form of NAFLD is characterized by inflammation and cellular injury, we evaluated the impact of AAA-1 on the expression of the hepatocellular injury marker Cytokeratin-18 (CK-18). Here, KRT18 is linked to metabolic dysfunction-associated steatohepatitis.